FDA Clears Greystone Medical Group's Epi-Max® For Sale In United States
FDA Clears Greystone Medical Group's Epi-Max® For Sale In United States
Greystone Medical Group announced recently that it has received U.S. FDA clearance to market and sell Epi-Max®, a wound care product created for the treatment of diabetic skin ulcers and other wound-related conditions. The FDA cleared Epi-Max® as a combination product, one of the few advanced wound care products that contains both a drug and a device.
Epi-Max® is a sterilized wound dressing impregnated with Greystone Medical Group's patented Poly Hydrated Ionogens (PHI) composition. Epi-Max® is designed to be the U.S. version of Greystone's DerMax® product, which has been approved as a medical device in Europe.
Tags:
None
Related: